期刊文献+

循环血miRNAs作为心血管疾病诊断标志物的研究

Circulating miRNAs as diagnosis biomarkers for cardiovascular diseases
原文传递
导出
摘要 MicroRNAs(miRNAs)是一类内源性非编码小分子RNAs,在转录后水平可与靶基因mRNAs的3′非翻译区结合而抑制基因表达,其表达具有组织特异性。功能学研究发现,细胞内miRNAs参与多种病理生理过程。近期发现miRNAs在循环血中以微泡、外核体、微粒以及凋亡小体等形式稳定存在,其水平可作为肿瘤等多种疾病诊断和预后的标志物。目前有关miRNAs可能作为心血管疾病诊断生物标志物的研究相继报道,本文将就循环血miRNAs作为急性心肌梗死、心力衰竭、冠状动脉疾病、糖尿病等心血管系统常见疾病的生物标志物的研究进展作一综述。 MicroRNAs (miRNAs) are a group of endogenous small non-coding RNAs, which play important gene regulatory roles at the post-transcriptional level by binding to the 3~ untranslated region of the targeted mRNAs. MiRNAs possess tissue-specific signatures and have been found involved in various pathophysiological processes. Recent reports have demonstrated that miRNAs are stably present in blood circulation in the form of microvesicles, exosome, microparticle, and apoptotic bodies; and the plasma levels of specific miRNAs have been proven as potential biomarkers for diagnosis and prognosis of cancers. Many articles have also reported that miRNAs can serve as important diagnostic biomarkers for cardiovascular diseases. Here we reviewed the roles of circulating miRNAs as potential biomarkers for cardiovascular diseases, including acute myocardial infarction, heart failure, coronary artery disease, and diabetes mellitus.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2012年第12期1365-1367,共3页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(31000354 30971231)~~
关键词 循环血微RNAs 心肌梗死 心力衰竭 冠状动脉疾病 糖尿病 生物标志物 circulating microRNAs myocardial infarctiom heart failure coronary artery disease diabetes mellitus~ biomarkers
  • 相关文献

参考文献24

  • 1Bartel D P. MicroRNAs: genomics, biogenesis?mechanism,andfunction[J], Cell,2004,116:281-297.
  • 2Lewis B P,Burge C B,Bartel D P. Conserved seed pairing,oftenflanked by adenosines?indicates that thousands of human genesare microRNA targets[J], Cell,2005,120:15-20.
  • 3Eldh M, Ekstrom K, Valadi H, Sjostrand M, Olsson B, JernasM,et al. Exosomes communicate protective messages during ox-idative stress; possible role of exosomal shuttle RNA[J]. PLoSOne,2010,5:el5353.
  • 4Prokopi M, Pula G, Mayr U? Devue C, Gallagher J, Xiao Q, et al.Proteomic analysis reveals presence of platelet microparticles in en-dothelial progenitor cell cultures[J]. Blood,2009,114:723-732.
  • 5Zernecke A,Bidzhekov K,Noels H?Shagdarsuren E,Gan L,De-necke B, et al. Delivery of microRNA-126 by apoptotic bodiesinduces CXCL12-dependent vascular protection[JJ. Sci Signal,2009,2:ra81.
  • 6Vickers K C,Palmisano B T,Shoucri B M,Shamburek R D,Re-maley A T. MicroRNAs are transported in plasma and deliveredto recipient cells by high-density lipoproteins[J]. Nat Cell Biol,2011,13:423-433.
  • 7Gupta S K, Bang C, Thum T. Circulating microRNAs as bio-markers and potential paracrine mediators of cardiovascular dis-ease[J], Circ Cardiovasc Genet,2010,3.-484-488.
  • 8Mitchell P S,Parkin R K,Kroh E M,Fritz B R, Wyman S K,Pogosova-Agadjanyan E L,et al. Circulating microRNAs as sta-ble blood-based markers for cancer detection [ J]. Proc NatlAcad Sci USA,2008,105 : 10513-10518.
  • 9Tanasijevic M J,Cannon C P, Antman E M,Wybenga D R,Fis-cher G A,Grudzien C,et al. Myoglobin, creatine-kinase-MB andcardiac troponin-I 60-minute ratios predict infarct-related arterypatency after thrombolysis for acute myocardial infarction: re-sults from the Thrombolysis in Myocardial Infarction study(TIMI) 10B[J]. J Am Coll Cardiol, 1999,34:739-747.
  • 10Horwich T B? Hamilton M A, Fonarow G C. B-type natriureticpeptide levels in obese patients with advanced heart failure[J]. JAm Coll Cardiol,2006,47 : 85-90.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部